CYTOSORBENTS CORPORATION: 10-Q filed 2016-05-09

Name: CYTOSORBENTS CORPORATION: 10-Q filed 2016-05-09
Creator: CYTOSORBENTS CORPORATION

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2016-05-09 (fiscal Q1 2016): 29 published measures, 60 facts as tagged in accession 0001144204-16-099906.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-05-09
Fiscal period: fiscal Q1 2016
Accession: 0001144204-16-099906 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-03-31	9,512,152	USD
At 2015-12-31	11,254,366	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-03-31	6,263,746	USD
At 2015-12-31	8,210,587	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-03-31	3,537,425	USD
At 2015-12-31	5,316,851	USD
At 2015-03-31	10,418,627	USD
At 2014-12-31	3,605,280	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-1,836,302	USD	91
2015-01-01 to 2015-03-31	-4,716,942	USD	90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	35,811	USD	91
2015-01-01 to 2015-03-31	104,005	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-03-31	-134,362,160	USD
At 2015-12-31	-132,525,858	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	0	USD	91
2015-01-01 to 2015-03-31	0	USD	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-03-31	569,222	USD
At 2015-12-31	557,289	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	107,083	USD	91
2015-01-01 to 2015-03-31	63,580	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-2,090,094	USD	91
2015-01-01 to 2015-03-31	-2,263,120	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-03-31	8,041,305	USD
At 2015-12-31	9,860,328	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-03-31	3,248,406	USD
At 2015-12-31	3,043,779	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-03-31	860,692	USD
At 2015-12-31	684,633	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-03-31	760,159	USD
At 2015-12-31	648,869	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	3,080,777	USD	91
2015-01-01 to 2015-03-31	2,681,713	USD	90

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-03-31	1,059,628	USD
At 2015-12-31	1,190,681	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	990,683	USD	91
2015-01-01 to 2015-03-31	418,593	USD	90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	1,970,104	USD	91
2015-01-01 to 2015-03-31	1,515,167	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	856,122	USD	91
2015-01-01 to 2015-03-31	951,028	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-03-31	25,406,056	shares
At 2015-12-31	25,397,056	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-03-31	140,261,680	USD
At 2015-12-31	140,126,731	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-03-31	338,820	USD
At 2015-12-31	584,317	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-03-31	901,625	USD
At 2015-12-31	836,749	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-03-31	194,093	USD
At 2015-12-31	511,927	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-2,081,798	USD	91
2015-01-01 to 2015-03-31	-4,372,763	USD	90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-1,836,302	USD	91
2015-01-01 to 2015-03-31	-4,716,942	USD	90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	253,792	USD	91
2015-01-01 to 2015-03-31	-2,453,822	USD	90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	95,116	USD	91
2015-01-01 to 2015-03-31	-104,425	USD	90

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-249,137	USD	91
2015-01-01 to 2015-03-31	140,711	USD	90

Inspect the source

Entity: CYTOSORBENTS CORPORATION / CIK 0001175151
Captured: 2026-09-20T07:44:44.168Z
SEC response SHA-256: 8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))